Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Infectious Disease ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.Crit Care Med. 2006; 34: 1589-1596
- The Association Between Antibiotic Delay Intervals and Hospital Mortality Among Patients Treated in the Emergency Department for Suspected Sepsis.Crit Care Med. 2021; 49: 741-747
- The Systemic Inflammatory Response Syndrome (SIRS) in acutely hospitalised medical patients: a cohort study.Scand J Trauma Resusc Emerg Med. 2009; 17: 67
- Likelihood of Bacterial Infection in Patients Treated With Broad-Spectrum IV Antibiotics in the Emergency Department.Crit Care Med. 2021; 49: e1144-e1150
- Evaluation of the Magicplex Sepsis Real-Time Test for the Rapid Diagnosis of Bloodstream Infections in Adults.Front Cell Infect Microbiol. 2019; 9: 56
- Enhanced Performance of Next-Generation Sequencing Diagnostics Compared With Standard of Care Microbiological Diagnostics in Patients Suffering From Septic Shock.Crit Care Med. 2019; 47: e394-e402
- The complete sequence of human preprocalcitonin.FEBS Lett. 1984; 167: 93-97
- High serum procalcitonin concentrations in patients with sepsis and infection.Lancet. 1993; 341: 515-518
- In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue.Endocrinology. 2003; 144: 5578-5584
- Procalcitonin as an Early Marker of the Need for Invasive Respiratory or Vasopressor Support in Adults With Community-Acquired Pneumonia.Chest. 2016; 150: 819-828
- Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia.Ann Emerg Med. 2008; 52: 48-58 e2
- Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia.Crit Care Med. 2011; 39: 2211-2217
- Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study.Crit Care. 2011; 15: R88
- Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients.Crit Care. 2013; 17: R115
- Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study.Crit Care Med. 2017; 45: 781-789
- A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU.Chest. 2008; 133: 610-617
- Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia.Clin Infect Dis. 2016; 62: 817-823
- The potential of molecular diagnostics and serum procalcitonin levels to change the antibiotic management of community-acquired pneumonia.Diagn Microbiol Infect Dis. 2016; 86: 102-107
- Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia.Clin Infect Dis. 2017; 65: 183-190
- Severe respiratory viral infection induces procalcitonin in the absence of bacterial pneumonia.Thorax. 2020; 75: 974-981
- Prognostic Value of Procalcitonin and C-Reactive Protein in 1608 Critically Ill Patients with Severe Influenza Pneumonia.Antibiotics (Basel). 2021; : 10https://doi.org/10.3390/antibiotics10040350
- Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America.Am J Respir Crit Care Med. 2019; 200: e45-e67
- Procalcitonin Is Useful for Evaluating Patients with Ambiguous Presentation and for Early Discontinuation of Antibiotics in Community-acquired Pneumonia.Am J Respir Crit Care Med. 2020; 201: 744-745
- Procalcitonin Is Not an Adequate Tool for Antimicrobial De-Escalation in Sepsis.Crit Care Med. 2020; 48: 1848-1850
- Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial.Clin Infect Dis. 2019; 69: 1091-1098
- Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by enterobacterales: a randomized, controlled trial: authors' response.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2021; https://doi.org/10.1016/j.cmi.2021.12.008
- Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.JAMA. 2003; 290: 2588-2598
- Early-onset ventilator-associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment.PloS one. 2012; 7e41290
- Duration of Antibiotic Use Among Adults With Uncomplicated Community-Acquired Pneumonia Requiring Hospitalization in the United States.Clin Infect Dis. 2018; 66: 1333-1341
- Excess Antibiotic Treatment Duration and Adverse Events in Patients Hospitalized With Pneumonia: A Multihospital Cohort Study.Ann Intern Med. 2019; 171: 153-163
- Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis.J Antimicrob Chemother. 2014; 69: 1748-1754
- Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital.Clin Infect Dis. 2004; 38: 348-356
- Outcome measurement of extensive implementation of antimicrobial stewardship in patients receiving intravenous antibiotics in a Japanese university hospital.Int J Clin Pract. 2012; 66: 999-1008
- Shortened Courses of Antibiotics for Bacterial Infections: A Systematic Review of Randomized Controlled Trials.Pharmacotherapy. 2018; 38: 674-687
- Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.Lancet. 2010; 375: 463-474
- Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.Lancet Infect Dis. 2016; 16: 819-827
- Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial.Am J Respir Crit Care Med. 2014; 190: 1102-1110
- Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial.Crit Care Med. 2011; 39: 2048-2058
- Effect of Procalcitonin Testing on Health-care Utilization and Costs in Critically Ill Patients in the United States.Chest. 2017; 151: 23-33
- Procalcitonin-guided Antibiotic Treatment in Patients With Positive Blood Cultures: A Patient-level Meta-analysis of Randomized Trials.Clin Infect Dis. 2019; 69: 388-396
- Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study.Clin Infect Dis. 2021; 72: e533-e541
- Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.Clin Microbiol Infect. 2020; 26: 1395-1399
- An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London.J Antimicrob Chemother. 2021; 76: 796-803
- Increased Incidence of Ventilator-Acquired Pneumonia in Coronavirus Disease 2019 Patients: A Multicentric Cohort Study.Crit Care Med. 2022; 50: 449-459
- Hospital-Acquired Infections in Critically Ill Patients With COVID-19.Chest. 2021; 160: 454-465
- Ventilator-Associated Lower Respiratory Tract Bacterial Infections in COVID-19 Compared With Non-COVID-19 Patients.Crit Care Med. 2022;
- Trends in Antibiotic Use in United States Hospitals During the Coronavirus Disease 2019 Pandemic.Open Forum Infect Dis. 2021; 8: ofab236
- Procalcitonin for the differential diagnosis of COVID-19 in the emergency department. Prospective monocentric study.Intern Emerg Med. 2021; 16: 1733-1735
- High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department.BMC Infect Dis. 2022; 22: 165
- Elevated Procalcitonin Is Positively Associated with the Severity of COVID-19: A Meta-Analysis Based on 10 Cohort Studies.Medicina (Kaunas). 2021; : 57
- Evaluation of procalcitonin as a contribution to antimicrobial stewardship in SARS-CoV-2 infection: a retrospective cohort study.The J Hosp Infect. 2021; 110: 103-107
- Procalcitonin as a biomarker for ventilator associated pneumonia in COVID-19 patients: Is it an useful stewardship tool?.Diagn Microbiol Infect Dis. 2021; 101: 115344
- Use of procalcitonin for antibiotic stewardship in patients with COVID-19: A quality improvement project in a district general hospital.Clin Med (Lond). 2021; 21: e71-e76
- Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care unit.J Glob Antimicrob Resist. 2020; 22: 782-784
- Procalcitonin as a biomarker for severe Plasmodium falciparum disease: a critical appraisal of a semi-quantitative point-of-care test in a cohort of travellers with imported malaria.Malar J. 2009; 8: 206
- Serum Procalcitonin and Peripheral Venous Lactate for Predicting Dengue Shock and/or Organ Failure: A Prospective Observational Study.Plos Negl Trop Dis. 2016; 10: e0004961
- Procalcitonin levels in candidemia versus bacteremia: a systematic review.Crit Care. 2019; 23: 190
- Use of procalcitonin in patients with various degrees of chronic kidney disease including renal replacement therapy.Clin Infect Dis. 2014; 59: 1761-1767
- Lung cancer may increase serum procalcitonin level.Infect Disord Drug Targets. 2015; 15: 57-63
- Role of Procalcitonin and Interleukin-6 in Predicting Cancer, and Its Progression Independent of Infection.PLoS One. 2015; 10e0130999
- Procalcitonin in hemodialysis patients presenting with fever or chills to the emergency department.Intern Emerg Med. 2020; 15: 257-262
- Diagnostic value of procalcitonin for bacterial infections in patients undergoing hemodialysis: a systematic review and meta-analysis.Ren Fail. 2022; 44: 81-93
- Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure.Crit Care. 2003; 7: R160-R166
- Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?.Infection. 2021; 49: 1107-1131
- Diagnosing Invasive Candidiasis.J Clin Microbiol. 2018; 56https://doi.org/10.1128/JCM.01909-17
- Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.Crit Care Med. 2021; 49: e1063-e1143
- The Treatment of Lobar Pneumonia and Pneumococcal Empyema with Penicillin.Bull N Y Acad Med. 1944; 20: 142-178
- Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection.New Engl J Med. 2018; 379: 236-249
- Prevalence of Discordant Procalcitonin Use at an Academic Medical Center.Am J Clin Pathol. 2021; https://doi.org/10.1093/ajcp/aqab201
- Biomarkers of Sepsis and Bloodstream Infections: The Role of Procalcitonin and Proadrenomedullin With Emphasis in Patients With Cancer.Clin Infect Dis. 2018; 67: 971-977
- Complementary Use of Presepsin with the Sepsis-3 Criteria Improved Identification of High-Risk Patients with Suspected Sepsis.Biomedicines. 2021; : 9https://doi.org/10.3390/biomedicines9091076
- Prognostication of Mortality in Critically Ill Patients With Severe Infections.Chest. 2015; 148: 674-682
- A host-protein based assay to differentiate between bacterial and viral infections in preschool children (OPPORTUNITY): a double-blind, multicentre, validation study.Lancet Infect Dis. 2017; 17: 431-440
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
